Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
-
Shares outstanding
-
265,957,447
-
Total 13F shares
-
143,579,673
-
Share change
-
-24,720,638
-
Total reported value
-
$233,669,297
-
Put/Call ratio
-
170%
-
Price per share
-
$1.63
-
Number of holders
-
95
-
Value change
-
-$67,552,879
-
Number of buys
-
46
-
Number of sells
-
35
Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q3 2025
As of 30 Sep 2025,
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
143,579,673 shares.
The largest 10 holders included
MAK CAPITAL ONE LLC, Blackstone Inc., Syncona Portfolio Ltd, ARMISTICE CAPITAL, LLC, TFG Asset Management GP Ltd, SCHRODER INVESTMENT MANAGEMENT GROUP, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Frazier Life Sciences Management, L.P., and BlackRock, Inc..
This page lists
95
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.